Immunoglobulins during the course of acute leukemia in children. Effects of various clinical factors.
D000208:Acute Disease; D000293:Adolescent; D000361:Agammaglobulinemia / Q000139:chemically induced*; D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000009:adverse effects; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007223:Infant; D007239:Infections / Q000276:immunology; D007938:Leukemia / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D011241:Prednisone / Q000009:adverse effects; D012709:Serum Albumin / Q000032:analysis
D000970:Antineoplastic Agents; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D012709:Serum Albumin; D003520:Cyclophosphamide; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin